Tech Company Financing Transactions
Vedanta Biosciences Funding Round
On 9/24/2019, Vedanta Biosciences landed $16.6 million in Series C funding from Bill & Melinda Gates Foundation, Bristol-Myers Squibb and FC Capital Partners.
Transaction Overview
Company Name
Announced On
9/24/2019
Transaction Type
Venture Equity
Amount
$16,600,000
Round
Series C
Investors
Proceeds Purpose
The funding further supports the expansion of Vedanta's broad clinical pipeline, including the recently launched Phase 1b/2 study of VE416 in food allergy, a planned Phase 1b/2 study of VE800 and OPDIVO (nivolumab) in advanced or metastatic cancers, and the ongoing Phase 2 study of VE303 in recurrent Clostridioides difficile infection (rCDI).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
19 Blackstone St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bernat Olle
Chief Financial Officer
Mark Mullikin
Chief Medical Officer
Jeffrey Silber
Chief Operating Officer
Daniel Couto
VP - Bus. Development
Taylor Feehley
VP - Finance
Maggie McGuigan
VP - Human Resources
Jack Kyte
VP - Manufacturing
Kris Ireland
VP - Operations
Lorraine Hughes
VP - Operations
Debra Winslow
VP - Regulatory Affairs
Anne Kuan
VP - Regulatory Affairs
Thomas O'Brien
Browse more venture capital transactions:
Prev: 9/24/2019: DustPhotonics venture capital transaction
Next: 9/24/2019: RedPoint Global venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs